161 related articles for article (PubMed ID: 10380355)
1. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
2. Human mucus protease inhibitor in airway fluids is a potential defensive compound against infection with influenza A and Sendai viruses.
Beppu Y; Imamura Y; Tashiro M; Towatari T; Ariga H; Kido H
J Biochem; 1997 Feb; 121(2):309-16. PubMed ID: 9089405
[TBL] [Abstract][Full Text] [Related]
3. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
Kido H; Murakami M; Oba K; Chen Y; Towatari T
Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
[TBL] [Abstract][Full Text] [Related]
4. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
Kido H; Niwa Y; Beppu Y; Towatari T
Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of proteolytic activation of Sendai virus infection and the defensive compounds for infection.
Kido H; Beppu Y; Sakai K; Towatari T
Biol Chem; 1997; 378(3-4):255-63. PubMed ID: 9165079
[TBL] [Abstract][Full Text] [Related]
6. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.
Tashiro M; Yokogoshi Y; Tobita K; Seto JT; Rott R; Kido H
J Virol; 1992 Dec; 66(12):7211-6. PubMed ID: 1331518
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of recombinant second domain variants of human mucus proteinase inhibitor (MPI).
Meckelein B; Kemme M; Nikiforov T; Appelhans H; Gassen HG
Biomed Biochim Acta; 1991; 50(4-6):673-6. PubMed ID: 1801741
[TBL] [Abstract][Full Text] [Related]
8. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization.
Chen Y; Shiota M; Ohuchi M; Towatari T; Tashiro J; Murakami M; Yano M; Yang B; Kido H
Eur J Biochem; 2000 Jun; 267(11):3189-97. PubMed ID: 10824103
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of pulmonary surfactant on Sendai virus infection in rat lungs.
Tashiro M; Beppu Y; Sakai K; Kido H
Arch Virol; 1996; 141(8):1571-7. PubMed ID: 8856034
[TBL] [Abstract][Full Text] [Related]
10. Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.
Kido H; Okumura Y; Yamada H; Mizuno D; Higashi Y; Yano M
Biol Chem; 2004 Nov; 385(11):1029-34. PubMed ID: 15576322
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
12. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
Fritz H
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
[TBL] [Abstract][Full Text] [Related]
13. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
[TBL] [Abstract][Full Text] [Related]
14. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
Hidari KI; Murata T; Yoshida K; Takahashi Y; Minamijima YH; Miwa Y; Adachi S; Ogata M; Usui T; Suzuki Y; Suzuki T
Glycobiology; 2008 Oct; 18(10):779-88. PubMed ID: 18621993
[TBL] [Abstract][Full Text] [Related]
15. Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis.
Grogan CC; Moyer SA
Virology; 2001 Sep; 288(1):96-108. PubMed ID: 11543662
[TBL] [Abstract][Full Text] [Related]
16. Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells.
Sakai K; Kohri T; Tashiro M; Kishino Y; Kido H
Eur Respir J; 1994 Apr; 7(4):686-92. PubMed ID: 8005249
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus.
Kido H; Sakai K; Kishino Y; Tashiro M
FEBS Lett; 1993 May; 322(2):115-9. PubMed ID: 8387030
[TBL] [Abstract][Full Text] [Related]
18. Mutations in murine Mx1: effects on localization and antiviral activity.
Garber EA; Hreniuk DL; Scheidel LM; van der Ploeg LH
Virology; 1993 Jun; 194(2):715-23. PubMed ID: 8389079
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of rhIFN-alpha 1 against seven influenza viruses.
Li F; Wang QJ; Zhu BL; Wang M
Zhongguo Yao Li Xue Bao; 1999 Aug; 20(8):709-14. PubMed ID: 10678103
[TBL] [Abstract][Full Text] [Related]
20. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
